Your browser is no longer supported. Please, upgrade your browser.
ECYT Endocyte, Inc. monthly Stock Chart
ECYT [NASD]
Endocyte, Inc.
Index- P/E- EPS (ttm)-1.16 Insider Own2.30% Shs Outstand64.21M Perf Week2.11%
Market Cap932.33M Forward P/E- EPS next Y-0.77 Insider Trans-4.44% Shs Float64.21M Perf Month7.48%
Income-52.20M PEG- EPS next Q-0.17 Inst Own77.40% Short Float5.58% Perf Quarter46.37%
Sales0.07M P/S12709.83 EPS this Y-20.60% Inst Trans120.37% Short Ratio2.58 Perf Half Y214.97%
Book/sh3.12 P/B4.65 EPS next Y-10.00% ROA-41.20% Target Price17.67 Perf Year855.26%
Cash/sh2.70 P/C5.39 EPS next 5Y- ROE-43.00% 52W Range1.17 - 15.45 Perf YTD239.25%
Dividend- P/FCF- EPS past 5Y-21.10% ROI- 52W High-6.02% Beta0.54
Dividend %- Quick Ratio37.80 Sales past 5Y- Gross Margin- 52W Low1141.03% ATR0.92
Employees44 Current Ratio37.80 Sales Q/Q26.80% Oper. Margin- RSI (14)63.92 Volatility6.20% 6.69%
OptionableYes Debt/Eq0.00 EPS Q/Q42.20% Profit Margin- Rel Volume0.75 Prev Close14.36
ShortableYes LT Debt/Eq0.00 EarningsMay 09 BMO Payout- Avg Volume1.39M Price14.52
Recom1.30 SMA204.69% SMA5024.20% SMA200125.87% Volume1,043,836 Change1.11%
Apr-13-18Initiated Jefferies Buy $17
Mar-09-18Initiated Wells Fargo Outperform $20
Oct-03-17Upgrade Wedbush Neutral → Outperform $2 → $7
Jun-05-17Downgrade Wedbush Outperform → Neutral $8 → $2
Mar-03-16Reiterated Wedbush Outperform $12 → $8
Jan-21-16Initiated Credit Suisse Outperform
Nov-04-15Reiterated RBC Capital Mkts Outperform $13 → $10
Aug-05-15Reiterated RBC Capital Mkts Outperform $15 → $13
Sep-30-14Downgrade Brean Capital Buy → Hold
Jul-08-14Resumed Brean Capital Buy $22
Jun-18-14Reiterated RBC Capital Mkts Outperform $20 → $15
Jun-18-14Reiterated Chardan Capital Markets Buy $26 → $15
May-05-14Reiterated RBC Capital Mkts Outperform $46 → $20
May-05-14Reiterated Chardan Capital Markets Buy $43 → $26
May-02-14Reiterated Brean Capital Buy $41 → $22
May-02-14Downgrade Robert W. Baird Outperform → Neutral $36 → $8
Mar-25-14Reiterated Chardan Capital Markets Buy $20 → $43
Mar-21-14Reiterated Brean Capital Buy $21 → $41
Sep-30-13Initiated Chardan Capital Markets Buy $20
Mar-25-13Upgrade Robert W. Baird Neutral → Outperform $9 → $13
Jun-08-18 10:37AM  Endocyte (ECYT) Up 5.1% Since Earnings Report: Can It Continue? Zacks +5.65%
Jun-05-18 08:01AM  Endocyte Announces Enrollment of First Patient in Phase 3 VISION Trial of 177Lu-PSMA-617 in Prostate Cancer GlobeNewswire
May-30-18 12:21PM  Marijuana Stock Among Four Moving Higher Forbes
12:14PM  Harry Boxers five momentum stocks to watch, including Canopy Growth and Impinj MarketWatch
May-29-18 04:30PM  Endocyte to Present at Jefferies Healthcare Conference GlobeNewswire
May-18-18 04:51PM  Winners and Losers From the Biggest Cancer Meeting of the Year (So Far) Motley Fool +6.96%
07:50AM  Blog Exposure - FDA Accepted for Review Insmeds Marketing Application for ALIS in NTM Lung Disease Caused by MAC ACCESSWIRE
May-17-18 12:19PM  Should You Be Concerned With Endocyte Incs (NASDAQ:ECYT) -15.38% Earnings Drop? Simply Wall St. +7.56%
May-16-18 06:05PM  Endocyte Announces Presentation of Phase 2 Data from Investigator-Initiated Prostate Cancer Trial of 177Lu-PSMA-617 at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting GlobeNewswire
May-12-18 11:53AM  These 5 Nasdaq Stocks Broke Out & Hit New 52-Week Highs Last Week Forbes
03:41AM  Edited Transcript of ECYT earnings conference call or presentation 9-May-18 12:30pm GMT Thomson Reuters StreetEvents
May-11-18 05:59AM  Endocyte (ECYT) Q1 Loss Narrower Than Expected, Shares Up Zacks
May-10-18 01:27PM  Four momentum stocks to watch amid earnings reports MarketWatch
May-09-18 09:30AM  Endocyte (ECYT) Posts Narrower than Expected Loss in Q1 Zacks +8.60%
08:28AM  Endocyte: 1Q Earnings Snapshot Associated Press
08:01AM  Endocyte Provides First Quarter 2018 Financial Results and Operational Update GlobeNewswire
08:01AM  Endocyte Announces The Lancet Oncology Publication of Phase 2 Data From Investigator-Initiated Prostate Cancer Trial of (177)Lu-PSMA-617 GlobeNewswire
May-08-18 06:24PM  What's in Store for Endocyte (ECYT) This Earnings Season? Zacks
May-07-18 08:43AM  Loss-Making Endocyte Inc (NASDAQ:ECYT) Expected To Breakeven Simply Wall St. +5.51%
May-04-18 09:23AM  Zacks.com highlights: Baytex Energy, Capstone Turbine, Endocyte, First BanCorp and FuelCell Zacks
May-02-18 08:01AM  Endocyte Announces First Quarter 2018 Earnings Call GlobeNewswire +7.82%
May-01-18 04:01PM  Endocyte to Present at Deutsche Bank's 43rd Annual Health Care Conference GlobeNewswire
Apr-26-18 08:20AM  New Research: Key Drivers of Growth for OFG, Oshkosh, Vishay Precision Group, Endocyte, BioCryst Pharmaceuticals, and Trevena Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Apr-16-18 09:00AM  Endocyte Presents Data from its CAR T Platform at American Association for Cancer Research (AACR) Annual Meeting 2018 GlobeNewswire
Apr-05-18 09:05AM  Zacks.com highlights: Stoneridge, FGL Holdings, Lindblad Expeditions Holdings, Endocyte and Knoll Zacks
Apr-04-18 10:54AM  New Analyst Coverage Puts Spotlight on 5 Stocks Zacks
Mar-29-18 08:48AM  These 3 Biotech Stocks Are Soaring, but Are They Buys Now? Motley Fool
Mar-19-18 09:02PM  These Stocks Have Quadrupled Since Mid-2017 Motley Fool
Mar-15-18 04:01PM  Endocyte Announces Presentations at American Association for Cancer Research (AACR) Annual Meeting 2018 GlobeNewswire
08:01AM  Endocyte Nominates Dawn Svoronos for Election to Its Board of Directors and Announces Other Board Developments GlobeNewswire
Mar-13-18 04:37PM  Why Ultra Petroleum, Endocyte, and MDC Holdings Jumped Today Motley Fool +22.54%
08:52AM  Endocyte (ECYT) Catches Eye: Stock Jumps 7.7% Zacks
Mar-08-18 01:56PM  Why Endocyte Stock Is on the Move Today Motley Fool +10.26%
Mar-05-18 04:01PM  Endocyte to Present at the Cowen and Company 38th Annual Health Care Conference GlobeNewswire
Mar-02-18 04:01PM  Endocyte Announces Closing of Public Offering of Common Stock GlobeNewswire +10.17%
Feb-28-18 09:18AM  Endocyte Announces Pricing of Public Offering of Common Stock GlobeNewswire +41.19%
Feb-27-18 06:49PM  Endocyte Announces Proposed Public Offering of Common Stock GlobeNewswire
04:01PM  Endocyte Appoints Patrick Machado, J.D. to Its Board of Directors GlobeNewswire
08:54AM  Endocyte (ECYT) Reports Wider-Than-Estimated Loss in Q4 Zacks
08:20AM  Todays Research Reports on Stocks to Watch: Endocyte and MyoKardia ACCESSWIRE
12:11AM  Edited Transcript of ECYT earnings conference call or presentation 26-Feb-18 1:30pm GMT Thomson Reuters StreetEvents
Feb-26-18 09:36AM  Endocyte (ECYT) Posts Wider than Expected Loss in Q4 Zacks +9.25%
08:33AM  Endocyte reports 4Q loss Associated Press
08:00AM  Endocyte Announces Phase 3 VISION Trial and Provides Update on Corporate Strategy and Reports Fourth Quarter and Year End 2017 Financial Results GlobeNewswire
08:00AM  Endocyte and ITM Announce Supply Agreement for No-Carrier-Added Lutetium for the Phase 3 VISION Trial GlobeNewswire
Feb-23-18 08:58AM  What's in Store for Endocyte (ECYT) This Earnings Season? Zacks
Feb-22-18 04:01PM  Endocyte Announces Fourth Quarter and Full Year 2017 Earnings Conference Call GlobeNewswire
Feb-15-18 07:40AM  New Research Coverage Highlights Trevena, Five Prime Therapeutics, Endocyte, FireEye, CSRA, and Orchid Island Capital Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire
Dec-27-17 08:56AM  Endocyte, Inc. :ECYT-US: Earnings Analysis: Q3, 2017 By the Numbers : December 27, 2017 Capital Cube
Dec-15-17 08:30AM  Options Traders Expect Huge Moves in Endocyte (ECYT) Stock Zacks
08:00AM  Endocyte Added to NASDAQ Biotechnology Index GlobeNewswire
Dec-04-17 04:48PM  Why Endocyte, Inc. Stock Briefly Spiked Today Motley Fool -6.05%
08:59AM  Options Traders Expect Huge Moves in Endocyte (ECYT) Stock Zacks
Nov-21-17 11:40AM  ETFs with exposure to Endocyte, Inc. : November 21, 2017 Capital Cube
Nov-09-17 04:01PM  Endocyte to Present at the Jefferies 2017 London Healthcare Conference GlobeNewswire +9.28%
07:18AM  Edited Transcript of ECYT earnings conference call or presentation 6-Nov-17 9:30pm GMT Thomson Reuters StreetEvents
Nov-07-17 09:19AM  Endocyte (ECYT) Posts Narrower-than-Expected Q3 Loss Zacks
Nov-06-17 04:09PM  Endocyte reports 3Q loss Associated Press
04:01PM  Endocyte Reports Third Quarter Financial Results GlobeNewswire
07:25AM  Endocyte, Inc. to Host Earnings Call ACCESSWIRE
Oct-31-17 11:49AM  Will Endocyte (ECYT) Disappoint This Earnings Season? Zacks
Oct-30-17 04:01PM  Endocyte Announces Third Quarter 2017 Earnings Conference Call GlobeNewswire
Oct-18-17 11:59AM  Why Endocyte Is Rallying Today Motley Fool +12.87%
Oct-10-17 08:31AM  Endocyte, Wedbush Analyst Upgrade, and the PSMA-617 Licensing Deal ACCESSWIRE
Oct-09-17 10:13AM  Cancer Space Last Week Update: Pipeline Expansion in Focus Zacks -9.74%
Oct-07-17 10:34AM  3 Drug Stocks That Soared This Week: Are They Buys? Motley Fool
Oct-04-17 07:54AM  Biotech Stock Roundup: Endocyte Shoots up on Deal, Amgen-AbbVie Settle Humira Litigation Zacks
Oct-03-17 04:58PM  Endocyte Inks Deal For Prostate Cancer Candidate, Shares Up Zacks +61.98%
02:36PM  Endocyte's stock rockets again on heavy volume after license deal for prostate cancer treatment MarketWatch
01:58PM  Why Endocyte, Inc. (ECYT) Stock Is Going Bonkers Today InvestorPlace
11:10AM  ETFs with exposure to Endocyte, Inc. : October 3, 2017 Capital Cube
09:00AM  Options Traders Expect Huge Moves in Endocyte (ECYT) Stock Zacks
08:20AM  Today's Research Reports on Stocks to Watch: Endocyte and INSYS Therapeutics ACCESSWIRE
Oct-02-17 04:40PM  Closing Bell; Endocyte Spikes: LIVE MARKETS BLOG TheStreet.com +157.45%
07:30AM  Endocyte Announces Exclusive Worldwide License of Phase 3 Ready PSMA-Targeted Radioligand Therapy for Development in Prostate Cancer GlobeNewswire
Sep-27-17 07:15PM  Bottom Fishing With Cash-Rich Biotechs GuruFocus.com
Sep-19-17 04:01PM  Endocyte to Present at the 2017 Cantor Global Healthcare Conference GlobeNewswire
Sep-06-17 08:00AM  Endocyte Presents Data at the 2017 CAR-TCR Summit Further Demonstrating the Ability to Manage Cytokine Release Syndrome Related to CAR T-Cell Therapy GlobeNewswire
Sep-05-17 04:01PM  Endocyte Announces Presentation at the European Society for Medical Oncology (ESMO) GlobeNewswire
Aug-31-17 06:14PM  ETFs with exposure to Endocyte, Inc. : August 31, 2017 Capital Cube
Aug-24-17 10:17AM  Endocyte, Inc. :ECYT-US: Earnings Analysis: Q2, 2017 By the Numbers : August 24, 2017 Capital Cube
Aug-16-17 04:20PM  Edited Transcript of ECYT earnings conference call or presentation 8-Aug-17 8:30pm GMT Thomson Reuters StreetEvents
08:00AM  Endocyte Announces Presentations at the 254th American Chemical Society National Meeting & Exposition GlobeNewswire
Aug-10-17 01:07AM  Endocyte reports 2Q loss Associated Press
Aug-09-17 10:53AM  Endocyte (ECYT) Stock Up Despite Wider-than-Expected Q2 Loss Zacks
Aug-08-17 04:01PM  Endocyte Reports Second Quarter Financial Results and Provides Clinical and Pipeline Update GlobeNewswire
10:10AM  Investor Network: Endocyte, Inc. to Host Earnings Call ACCESSWIRE
Aug-04-17 10:07AM  Spectrum (SPPI) Q2 Loss Narrower than Expected, Sales Beat Zacks
09:47AM  Shire (SHPG) Beats on Q2 Earnings & Sales, Updates '17 View Zacks
Aug-01-17 04:01PM  Endocyte Announces Second Quarter 2017 Earnings Conference Call GlobeNewswire
Jul-26-17 10:59AM  What's in Store for Endocyte (ECYT) this Earnings Season? Zacks
Jul-13-17 10:36AM  Endocyte (ECYT) to Focus on Promising CAR-T Cell Platform Zacks
Jun-20-17 02:53PM  ETFs with exposure to Endocyte, Inc. : June 20, 2017 Capital Cube
Jun-14-17 06:06AM  Why Is Endocyte (ECYT) Down 37.9% Since the Last Earnings Report? Zacks
Jun-05-17 02:13PM  ETFs with exposure to Endocyte, Inc. : June 5, 2017 Capital Cube -7.85%
Jun-02-17 09:36AM  Endocyte, Inc. :ECYT-US: Earnings Analysis: Q1, 2017 By the Numbers : June 2, 2017 Capital Cube -30.04%
08:42AM  Endocyte stock plummets 30% on news of major workforce reduction; clinical trial changes MarketWatch
08:02AM  Endocyte Announces Clinical Updates for EC1456 and EC1169 GlobeNewswire
May-31-17 08:15AM  Blog Coverage: Endocyte to Present Posters on its Lead Clinical Stage Assets at the ASCO Annual Meeting Accesswire -6.59%
08:00AM  Today's Research Reports on Stocks to Watch: Endocyte and CytRx Accesswire
Endocyte, Inc., a biopharmaceutical company, develops targeted therapies for the treatment of cancer and inflammatory diseases in the United States. The company uses its technology to create novel small molecule drug conjugates (SMDCs) and companion imaging agents. It is developing Vintafolide, a SMDC that is in Phase IIb clinical trial to treat non-small cell lung cancer; EC1456, which is in Phase I dose escalation trial for the treatment of advanced solid tumors; and EC1169, a tubulysin therapeutic that is in Phase I dose escalation trial to treat advanced metastatic castration-resistant prostate cancer. The company's products in pre-clinical development include EC2629, a folate receptor-targeted SMDC for use in treating cancer; EC2319 for the treatment of inflammatory diseases; EC0371 for treating polycystic kidney disease; and SMDC bi-specific adaptor chimeric antigen receptor T-cell for the treatment of immunotherapy in cancer. Endocyte, Inc. has a collaboration agreement with Purdue Research Foundation; Master License Agreement with Purdue Research Foundation; Merck Sharp & Dohme Research GmbH; and Nihon Medi-Physic Co., LTD. The company was founded in 1995 and is headquartered in West Lafayette, Indiana.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Leamon Christopher PVice President of ResearchJun 12Sale15.0613,089197,058130,381Jun 13 03:30 PM
Leamon Christopher PVice President of ResearchMar 09Sale9.075,03645,677143,470Mar 12 01:33 PM
Sherman Michael A.President and CEOFeb 02Option Exercise3.065,45316,686338,564Feb 06 12:01 PM
Low Philip SChief Science OfficerDec 28Option Exercise3.0665,445200,262354,050Jan 02 03:39 PM
Low Philip SChief Science OfficerDec 28Sale4.4150,511222,824303,539Jan 02 03:39 PM
Leamon Christopher PVice President of ResearchDec 01Option Exercise3.0626,17880,105150,579Dec 04 03:56 PM
Leamon Christopher PVice President of ResearchDec 01Sale5.0423,231116,983127,348Dec 04 03:56 PM
Low Philip SChief Science OfficerNov 13Buy4.845,60027,104288,605Nov 14 03:26 PM